awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38379114-7E1B6ABA-062E-4A91-9CC0-AE0DC9DC9752
Q38379114-7E1B6ABA-062E-4A91-9CC0-AE0DC9DC9752
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38379114-7E1B6ABA-062E-4A91-9CC0-AE0DC9DC9752
A phase Ib dose-escalation study of the MEK inhibitor trametinib in combination with the PI3K/mTOR inhibitor GSK2126458 in patients with advanced solid tumors.
P2860
Q38379114-7E1B6ABA-062E-4A91-9CC0-AE0DC9DC9752
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38379114-7E1B6ABA-062E-4A91-9CC0-AE0DC9DC9752
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
33acca0bd0d6677ed15bc704edde6cbf585f1311
P2860
Design of phase I combination trials: recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee